Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secondary Cytoreductive Surgery With or Without Carboplatin HIPEC in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT01767675Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jan 2013
- Primary completion
- Aug 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Memorial Sloan Kettering Cancer Center. Started Jan 2013; status: completed.
02
Drugs
carboplatin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01767675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767675.